Page 443 - Cote clinical veterinary advisor dogs and cats 4th
P. 443

Color Disorders of the Skin and Haircoat   195


           Chronic Treatment                      products have equivalent bioavailability.   signs. Prognosis for cure is poor because TC
           •  Medical management: most (71%-93%) dogs   Consider switching bronchodilators if   is irreversible and progressive, but prognosis
  VetBooks.ir  •  Maintain  ideal/lean  body  condition  score   develop toxicosis at doses that are well   •  Dogs with severe clinical signs (e.g., cyanosis,   Diseases and   Disorders
                                                                                    for survival is good.
                                                  no improvement. Certain animals may
             respond well
             (BCS, 4-5/9)
                                                  tolerated by others.
                                                                                    syncope) have a guarded prognosis that may
           •  Avoid environmental triggers (e.g., inhaled
             irritants, excessive excitement, hot/humid   •  Tracheal  stents:  salvage  procedure  (failed   improve with stent placement.
                                                medical management or respiratory distress).
             environments,  neck leads [harnesses   Consult with specialist in internal medicine,    PEARLS & CONSIDERATIONS
             preferred])                        surgery, or interventional radiology.
           •  Antitussives: reduce clinical signs and tracheal   ○   Surgical implantation of external prosthetic   Comments
             inflammation                         rings: generally limited to cervical trachea  Hydrocodone cough suppressants can be dif-
             ○   Hydrocodone 0.22 mg/kg PO q 6-12h,   ○   Intraluminal stents: cervical or thoracic   ficult to obtain. Many are combined with other
               or                                 collapse, placed with endoscopic or fluo-  medications (acetaminophen, guaifenesin, and
             ○   Butorphanol 0.55-1 mg/kg PO q 8-12h  roscopic guidance. Relieves obstruction to   various antihistamines) that may not be safe
             ○   Alternatives: maropitant 2 mg/kg q 48h;   airflow but not necessarily cough  or routinely recommended. Controlled drug
               Lomotil 0⋅2-0⋅5 mg/kg PO q 12h                                     status limits refill options.
           •  Antiinflammatory prednisone (short course):   Behavior/Exercise
             decrease laryngeal/tracheal inflammation  Weight loss with controlled exercise regimens   Prevention
             ○   Prednisone 0.5-1 mg/kg PO q 24h tapered   and dietary management improves clinical signs   Do not be breed affected dogs.
               and discontinued after 5-7 days  in many dogs.
           •  Manage comorbid conditions (e.g., chronic                           Technician Tips
             bronchitis [p. 136])              Possible Complications             When performing radiographs to evaluate for
             ○   Consider empiric short course of antimi-  •  Acute upper airway obstruction and death  TC, obtain inspiratory and expiratory films,
               crobial appropriate for airway infection   •  Cough suppressants: sedation  including the cervical and thoracic trachea.
               (e.g., doxycycline 5 mg/kg PO q 12h for   •  Stents: stent migration, stent fracture, exuber-
               7 days)                          ant granulation tissue, tracheitis, cough  Client Education
           •  Bronchodilators:  controversial;  has  not   ○   Coughing increases risk of stent fracture;   For most dogs, tracheal collapse is managed
             been critically evaluated in dogs with TC.   antitussives are frequently needed after   with weight control, antitussives, and periodic
             Consider as a trial in refractory patients   stenting.               administration of antiinflammatory drugs.
             (withdraw if there is no improvement).
             ○   Beta-2 agonists: terbutaline (total amount   Recommended Monitoring  SUGGESTED READING
               per dose): small dogs, 0.625-1.25 mg PO   Clinical signs           Tappin SW: Canine tracheal collapse. J Small Anim
               q 12h; medium dogs, 1.25-2.5 mg PO q                                Pract 57:9-17, 2016.
               12h; large dogs, 2.5-5 mg PO q 12h; or    PROGNOSIS & OUTCOME
               albuterol 0.05 mg/kg PO q 8h                                       AUTHOR: Laura Ridge Cousins, DVM, MS, DACVIM
             ○   Methylxanthines. extended-release the-  •  Despite improvement with treatment, many   EDITOR: Megan Grobman, DVM, MS, DACVIM
               ophylline  10 mg/kg  PO  q  12h;  not  all   dogs show some degree of persistent clinical







            Color Disorders of the Skin and Haircoat



            BASIC INFORMATION                  •  Papillomavirus-associated  plaques:  pug,   CONTAGION AND ZOONOSIS
                                                miniature schnauzer, Shar-pei     Hyperpigmentation:  dermatophytosis  and
           Definition                          Hypopigmentation:                  Sarcoptes scabiei are zoonotic.
           Very common spectrum of innate or acquired   •  Vitiligo: rottweiler, Belgian shepherd, Siamese
           pigmentary abnormalities of the skin or hair  cat, others              GEOGRAPHY AND SEASONALITY
                                               •  Idiopathic acquired nasal hypopigmentation   •  Snow  nose:  decreased  nasal  pigmentation
           Synonyms                             (“snow nose”): Labrador and golden retriev-  during winter months
           •  Hyperpigmentation, melanoderma, melano-  ers, Siberian husky        •  Recurrent flank alopecia: can be seasonal
             trichia                           •  Waardenburg-Klein syndrome: white cats,   •  Leishmaniasis:  highly  varied  geographic
           •  Hypopigmentation, depigmentation, leuko-  Dalmatian, bull terrier, others  distribution
             derma, leukotrichia, achromotrichia, poliosis  •  Premature  graying:  golden  and  Labrador
                                                retrievers, Irish setter          ASSOCIATED DISORDERS
           Epidemiology                        •  Dermatomyositis: Shetland sheepdog, collie  •  Postinflammatory  hyperpigmentation  or
           SPECIES, AGE, SEX                   •  Color dilution alopecia: blue or fawn Dober-  hypopigmentation:  many (see Differential
           Although some conditions are present at birth   man pinscher and many others  Diagnosis below)
           (e.g., albinism), most are acquired.  •  Canine  cyclic  hematopoiesis:  collie  (gray   •  Waardenburg-Klein  syndrome:  blue  eyes,
                                                collie syndrome, rare)              deafness
           GENETICS, BREED PREDISPOSITION      •  Chédiak-Higashi syndrome: Persian cat (rare)  •  Uveodermatologic syndrome: uveitis, blindness
           Hyperpigmentation:                                                     •  Dermatomyositis: myositis possible
           •  Recurrent  flank  alopecia:  boxer,  English   RISK FACTORS         •  Chédiak-Higashi  syndrome:  immunologic
             bulldog, Airedale terrier         Various, including heredity          deficiency

                                                      www.ExpertConsult.com
   438   439   440   441   442   443   444   445   446   447   448